Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry.
暂无分享,去创建一个
L. Balaspiri | M. Mâk | Z Skribanek | L Baláspiri | M Mák | Z. Skribanek | Lajos Baláspiri | Marianna Mák
[1] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[2] R. Wetzel,et al. Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] Xiongfong Chen,et al. Simultaneous assessment of conformation and aggregation of β‐amyloid peptide using electrospray ionization mass spectrometry , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[5] T. Holzman,et al. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.
[6] C. Barrow,et al. On-line high-performance liquid chromatography/mass spectrometric investigation of amyloid-beta peptide variants found in Alzheimer's disease. , 1999, Rapid communications in mass spectrometry : RCM.
[7] G. Fasman,et al. Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. , 1992, Analytical biochemistry.
[8] D. Wemmer,et al. Use of nuclear magnetic resonance in probing ligand-macromolecule interactions. , 1994, Methods in enzymology.
[9] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[10] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[11] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Camilleri,et al. β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptide , 1994 .
[13] R. Beavis,et al. Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure , 1995, Neuroscience Letters.
[14] C. Soto,et al. Inhibition of Alzheimer β-Fibrillogenesis by Melatonin* , 1998, The Journal of Biological Chemistry.
[15] R. Reiter,et al. Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide , 1997, The Journal of Neuroscience.
[16] T. Bandiera,et al. Inhibitors of Aβ Peptide Aggregation as Potential anti-Alzheimer Agents , 1997 .
[17] J. Seelig,et al. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. , 1995, Journal of molecular biology.
[18] C. Barrow,et al. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. , 1992, Biochemistry.
[19] D. Butterfield,et al. Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons , 1995, Experimental Neurology.
[20] C. Barrow,et al. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.
[21] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .